Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

The effect of polyphenolic extract from pine bark, Pycnogenol on the level of glutathione in children suffering from attention deficit hyperactivity disorder (ADHD).

Dvoráková M, Sivonová M, Trebatická J, Skodácek I, Waczuliková I, Muchová J, Duracková Z.

Redox Rep. 2006;11(4):163-72.

PMID:
16984739
2.

Effect of polyphenolic extract, Pycnogenol, on the level of 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder.

Chovanová Z, Muchová J, Sivonová M, Dvoráková M, Zitnanová I, Waczulíková I, Trebatická J, Skodácek I, Duracková Z.

Free Radic Res. 2006 Sep;40(9):1003-10.

PMID:
17015282
3.

Urinary catecholamines in children with attention deficit hyperactivity disorder (ADHD): modulation by a polyphenolic extract from pine bark (pycnogenol).

Dvoráková M, Jezová D, Blazícek P, Trebatická J, Skodácek I, Suba J, Iveta W, Rohdewald P, Duracková Z.

Nutr Neurosci. 2007 Jun-Aug;10(3-4):151-7.

PMID:
18019397
4.

Treatment of ADHD with French maritime pine bark extract, Pycnogenol.

Trebatická J, Kopasová S, Hradecná Z, Cinovský K, Skodácek I, Suba J, Muchová J, Zitnanová I, Waczulíková I, Rohdewald P, Duracková Z.

Eur Child Adolesc Psychiatry. 2006 Sep;15(6):329-35. Epub 2006 May 13.

PMID:
16699814
5.

An experimental comparison of Pycnogenol and methylphenidate in adults with Attention-Deficit/Hyperactivity Disorder (ADHD).

Tenenbaum S, Paull JC, Sparrow EP, Dodd DK, Green L.

J Atten Disord. 2002 Sep;6(2):49-60.

PMID:
12142861
6.

Pycnogenol: a blend of procyanidins with multifaceted therapeutic applications?

D'Andrea G.

Fitoterapia. 2010 Oct;81(7):724-36. doi: 10.1016/j.fitote.2010.06.011. Epub 2010 Jun 20. Review.

PMID:
20598812
7.

Pycnogenol® (extract of French maritime pine bark) for the treatment of chronic disorders.

Schoonees A, Visser J, Musekiwa A, Volmink J.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD008294. doi: 10.1002/14651858.CD008294.pub4. Review.

PMID:
22513958
8.

Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study.

Enseleit F, Sudano I, Périat D, Winnik S, Wolfrum M, Flammer AJ, Fröhlich GM, Kaiser P, Hirt A, Haile SR, Krasniqi N, Matter CM, Uhlenhut K, Högger P, Neidhart M, Lüscher TF, Ruschitzka F, Noll G.

Eur Heart J. 2012 Jul;33(13):1589-97. doi: 10.1093/eurheartj/ehr482. Epub 2012 Jan 11.

PMID:
22240497
9.

Effect of pine bark extract (Pycnogenol) on symptoms of knee osteoarthritis.

Cisár P, Jány R, Waczulíková I, Sumegová K, Muchová J, Vojtassák J, Duraćková Z, Lisý M, Rohdewald P.

Phytother Res. 2008 Aug;22(8):1087-92. doi: 10.1002/ptr.2461.

PMID:
18570266
10.
11.

Pycnogenol, French maritime pine bark extract, augments endothelium-dependent vasodilation in humans.

Nishioka K, Hidaka T, Nakamura S, Umemura T, Jitsuiki D, Soga J, Goto C, Chayama K, Yoshizumi M, Higashi Y.

Hypertens Res. 2007 Sep;30(9):775-80.

PMID:
18037769
12.

A randomised, double-blind, placebo-controlled trial on the effect of Pycnogenol on the climacteric syndrome in peri-menopausal women.

Yang HM, Liao MF, Zhu SY, Liao MN, Rohdewald P.

Acta Obstet Gynecol Scand. 2007;86(8):978-85.

PMID:
17653885
13.

Pycnogenol(®) for the treatment of chronic disorders.

Schoonees A, Visser J, Musekiwa A, Volmink J.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD008294. doi: 10.1002/14651858.CD008294.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;(4):CD008294.

PMID:
22336841
14.

Attention Deficit Hyperactivity Disorder and oxidative stress: A short term follow up study.

Guney E, Cetin FH, Alisik M, Tunca H, Tas Torun Y, Iseri E, Isik Taner Y, Cayci B, Erel O.

Psychiatry Res. 2015 Sep 30;229(1-2):310-7. doi: 10.1016/j.psychres.2015.07.003. Epub 2015 Jul 8.

PMID:
26188640
15.

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.

Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ.

Pediatrics. 2004 Jul;114(1):e1-8.

PMID:
15231966
16.

Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation.

Zibadi S, Rohdewald PJ, Park D, Watson RR.

Nutr Res. 2008 May;28(5):315-20. doi: 10.1016/j.nutres.2008.03.003.

PMID:
19083426
17.

Antidiabetic effect of Pycnogenol French maritime pine bark extract in patients with diabetes type II.

Liu X, Wei J, Tan F, Zhou S, Würthwein G, Rohdewald P.

Life Sci. 2004 Oct 8;75(21):2505-13.

PMID:
15363656
19.

Treatment of melasma with Pycnogenol.

Ni Z, Mu Y, Gulati O.

Phytother Res. 2002 Sep;16(6):567-71.

PMID:
12237816
20.

Effect of n-3 supplementation on hyperactivity, oxidative stress and inflammatory mediators in children with attention-deficit-hyperactivity disorder.

Hariri M, Djazayery A, Djalali M, Saedisomeolia A, Rahimi A, Abdolahian E.

Malays J Nutr. 2012 Dec;18(3):329-35.

PMID:
24568073

Supplemental Content

Support Center